GF
Gerald W. Fischer

Highly Cited

163
Works
3,392
Citations
30
H-Index
Search Authors
Author Statistics
External Links
OpenAlex Profile ORCID Profile

Gerald W. Fischer

Also known as: F. Gerald, Fischer, G W, Fischer, Gerald W., G W Fischer, G. Fischer

163

Total Works

3,392

Citations

30

H-Index

84

i10-Index

Citation & Works Trend by Year
44 years active
Top Research Topics
Neonatal and Maternal Infections (69) Monoclonal and Polyclonal Antibodies Research (35) Streptococcal Infections and Treatments (32) Immunodeficiency and Autoimmune Disorders (30) Bacterial Infections and Vaccines (25)
Recent Publications
15 shown
Year Publication Title Citations Action
2026 Immunogenicity of a Multi‐Epitope Influenza Composite Peptide Vaccine Targeting Human, Swine, and Avian Viruses: Advancing Pandemic Preparedness Influenza and Other Respiratory Viruses 0
2025 Successful Inactivation of High-Consequence Pathogens in PrimeStore Molecular Transport Media Viruses 2
2025 P-1073. Developing Vaccines and Antibodies Targeting Conserved Peptidoglycan, Lipoteichoic Acid, and Lipopolysaccharide Epitopes to Combat Antimicrobial Resistance Open Forum Infectious Diseases 1
2025 P-43. A Single Composite Peptide Vaccine Comprising Conserved Influenza Epitopes Formulated with ALFQ Adjuvant Induced Broadly Reactive Antibodies to Human, Avian, and Swine Influenza Viruses Open Forum Infectious Diseases 0
2024 In vitro evaluation of the binding activity of novel mouse IgG1 opsonic monoclonal antibodies to Mycobacterium tuberculosis and other selected mycobacterial species Journal of Clinical Tuberculosis and Other Mycobacterial Diseases 0
2023 1169. Unconjugated Multi-epitope Peptides Adjuvanted with ALFQ Induce Durable and Broadly Reactive Antibodies to Human and Avian Influenza Viruses Open Forum Infectious Diseases 0
2023 Unconjugated Multi-Epitope Peptides Adjuvanted with ALFQ Induce Durable and Broadly Reactive Antibodies to Human and Avian Influenza Viruses Vaccines 4
2022 2318. A Composite Peptide Vaccine Comprised of Conserved SARS-CoV-2 and Influenza Epitopes Generated Antisera Reponses to Both Coronavirus and Influenza Open Forum Infectious Diseases 0
2022 1706. IgM Monoclonal Antibodies Targeting Peptidoglycan May Provide Therapeutic Strategies against Antimicrobial Resistant Bacteria Open Forum Infectious Diseases 1
2021 Conserved Influenza Hemagglutinin, Neuraminidase and Matrix Peptides Adjuvanted with ALFQ Induce Broadly Neutralizing Antibodies Vaccines 10
2021 Rapid and Safe Detection of SARS-CoV-2 and Influenza Virus RNA Using Onsite Quantitative PCR Diagnostic Testing From Clinical Specimens Collected in Molecular Transport Medium The Journal of Applied Laboratory Medicine 11
2020 Whole genome sequencing of the highly virulent subtype B0/W148 of the Beijing genotype M.tuberculosis in Kharkiv, East Ukraine Tuberculosis 3
2019 2752. Peptide Vaccines Utilizing Conserved Hemagglutinin, Neuraminidase, and Matrix Ectodomain Influenza Epitopes Demonstrate Functional Activity Against Group 1 and 2 Influenza Strains Open Forum Infectious Diseases 0
2019 Erratum to “Opsonic monoclonal antibodies enhance phagocytic killing activity and clearance of Mycobacterium tuberculosis from blood in a quantitative qPCR mouse model” [Heliyon 5 (9), (September 2019), e02260] Heliyon 0
2019 Opsonic monoclonal antibodies enhance phagocytic killing activity and clearance of Mycobacterium tuberculosis from blood in a quantitative qPCR mouse model Heliyon 3

Data source: OpenAlex API